Botulinum toxin type A was first used for the treatment of spasticity in 1989. A small uncontrolled study of treatment of upper limb spasticity after stroke reported encouraging benefits, including ...

Spasticity most often develops in upper motor neuron types of injuries. It is a motor disorder defined as velocity dependent, increased resistance to passive muscle stretch. It is an exaggeration of ...

Spasticity is a condition that causes your muscles to stiffen, tighten, and contract. It happens involuntarily, which means you don’t have control over it. Spasticity typically happens because of ...

International survey presented at TOXINS 2019 reveals hidden burden of spasticity 1 PARIS--(BUSINESS WIRE)--Regulatory News: Ipsen (Euronext: IPN; ADR: IPSEY) today presents at TOXINS, results from an ...

Spasticity is a clinical sign characterized by muscle over-activity and high tone spasms that is associated with several distinct neurological diseases. Timely diagnosis and management are essential ...

Although spasticity is a condition involving unusual tightness of muscles in the body, the cause typically originates from an injury to or disorder of the central nervous system (CNS). Image Credit: ...

Spasticity is a condition that affects your muscles, making them tight or stiff. This can impact your ability to perform daily activities, such as walking, eating, and talking. The condition may also ...

Cerebral palsy (CP) is a lifelong congenital condition that causes palsy, or impaired movements, due to brain damage at a very young age. Spastic quadriplegic cerebral palsy (SQCP) is a severe type ...

Despite the seriousness of botulism, local injections of botulinum toxin type A are well tolerated and serious side effects are rare. Adverse events can be classified as local or systemic. [56] Local ...